Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ren Yamada

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Plos One|July 1, 2022
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patientsMasato Nakai, Goki Suda, Koji Ogawa, et al.
Journal of Gastroenterology|April 27, 2023
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosisMasato Nakai, Kenichi Morikawa, Takashi Sasaki, et al.
Journal of Gastroenterology|August 28, 2020
Durable response without recurrence to Tolvaptan improves long-term survivalMasato Nakai, Goki Suda, Akinori Kubo, et al.
Journal of Viral Hepatitis|February 15, 2021
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle massYoshimasa Tokuchi, Goki Suda, Megumi Kimura, et al.
Scientific Reports|January 28, 2022
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradicationMasato Nakai, Yoshiya Yamamoto, Masaru Baba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 31, 2020
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19Goki Suda, Koji Ogawa, Megumi Kimura, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 26, 2020
Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinomaTaku Shigesawa, Goki Suda, Megumi Kimura, et al.
Cancers|July 24, 2021
Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRIAkinori Kubo, Goki Suda, Megumi Kimura, et al.
Plos One|March 1, 2021
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinomaTaku Shigesawa, Goki Suda, Megumi Kimura, et al.
Scientific Reports|April 29, 2021
Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis CNaoki Kawagishi, Goki Suda, Megumi Kimura, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Plos One|July 1, 2022
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patientsMasato Nakai, Goki Suda, Koji Ogawa, et al.
Journal of Gastroenterology|April 27, 2023
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosisMasato Nakai, Kenichi Morikawa, Takashi Sasaki, et al.
Journal of Gastroenterology|August 28, 2020
Durable response without recurrence to Tolvaptan improves long-term survivalMasato Nakai, Goki Suda, Akinori Kubo, et al.
Journal of Viral Hepatitis|February 15, 2021
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle massYoshimasa Tokuchi, Goki Suda, Megumi Kimura, et al.
Scientific Reports|January 28, 2022
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradicationMasato Nakai, Yoshiya Yamamoto, Masaru Baba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 31, 2020
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19Goki Suda, Koji Ogawa, Megumi Kimura, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 26, 2020
Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinomaTaku Shigesawa, Goki Suda, Megumi Kimura, et al.
Cancers|July 24, 2021
Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRIAkinori Kubo, Goki Suda, Megumi Kimura, et al.
Plos One|March 1, 2021
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinomaTaku Shigesawa, Goki Suda, Megumi Kimura, et al.
Scientific Reports|April 29, 2021
Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis CNaoki Kawagishi, Goki Suda, Megumi Kimura, et al.
Pageof 5